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ABSTRACT 
Objective: Camellia sinensis (C. sinensis family-Theaceae) has potent antioxidant activity used in the treatment of cardiovascular disease. The 
present study evaluates the cardioprotective (anti-hypertrophic) effect of aqueous extract of C. sinensis in isoproterenol (ISO) induced cardiac 
hypertrophic rats. 
Methods: The beneficial effect of the green tea extract was examined by the administration of the aqueous extract of the leaves of C. sinensis (100 
mg/kg b.w., oral., 7 d) in ISO (10 mg/kg b.w., subcutaneous.,7 d) induced cardiac hypertrophic rats with reference to the standard drug, losartan (50 
mg/kg b.w., oral.,7 d) followed by biochemical estimations of glucose, protein, cholesterol, cardiac marker enzymes namely serum glutamate 
oxaloacetate transaminase (SGOT), serum glutamate pyruvate transaminase (SGPT) and lactate dehydrogenase (LDH) in serum and heart tissues 
thus collected at the end of 7 d. 
Results: The biochemical assays revealed significantly (P<0.05) increased glucose, protein, cholesterol, cardiac marker enzymes namely serum 
glutamate oxaloacetate transaminase (SGOT), serum glutamate pyruvate transaminase (SGPT) lactate dehydrogenase (LDH) and significantly 
(P<0.05) decreased in ISO induced cardiac hypertrophic rats that were reciprocated by the effect of plant extract.  
Conclusion: Thus, this study showed that the aqueous leaf extract of C. sinensis possesses potent effect against cardiac hypertrophy. This potential 
is hypothesized to be due to the phytochemical, Catechin present in the plant that requires further isolation and characterization with respect to 
anti-hypertrophic therapeutics. 
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Cardiovascular disease (CVD) is one of the leading causes of death 
globally, more people die annually from CVDs than from any other 
cause. An estimated, 17.7 million people died from cardiovascular 
diseases in 2015, representing 31% of all global deaths. Out of these 
deaths, 7.4 million were due to coronary heart disease and 6.7 
million were due to Stroke. Over three quarters of CVD deaths take 
place in low and middle-income countries. Among 17 million 
premature deaths (under the age of 70) due to non-communicable 
diseases in 2015, 37% are caused by cardiovascular diseases and 
82% are in low and middle-income countries. 
“Cardiac hypertrophy is the abnormal enlargement or thickening of 
the heart muscle resulting from increases in cardiomyocyte size and 
changes in other heart muscle components, such as extracellular 
matrix”. Hypertrophic growth accompanies many forms of 
cardiovascular diseases such as hypertension, heart failure and 
valvular disease [1]. It is a response of myocardium to various 
physiologic and pathologic stimuli that causes the heart to work 
harder under condition of increased workload [2].  
Administration of several medicinal plants have restored the 
activities of certain serum cardiac enzymes when compared to 
normal control groups [3]. The active phytoconstituents of various 
plant species are isolated for the direct use of drugs, lead 
compounds or pharmacological agents. 
Green tea (Camellia sinensis or C. sinensis; family-Theaceae) is made 
from more nature tea leaves, and they may be withered prior to 
steaming or firing. Although they are also rich in catechins, green tea 
may have catechins profiles different from other tea with slightly 
higher levels of oxidation products [4]. Tea catechins can act as 
antioxidants by donation of a hydrogen atom, as an acceptor of free 
radicals, interrupting chain oxidation reactions, or by chelating 
metals [5]. The active ingredients present in the tea leaves is 
polyphenol and it’s the important biological compound [6]. 
Furthermore, this plant has several medicinal values attributed to 
high polyphenol contents having tremendous impact on health [7]. 
Many of the studies of polyphenols and catechins reports 
mechanisms with protection against degenerative diseases [8, 9]. 
Green tea has hepatoprotective activity [10], antidiabetic effect [11], 
cardioprotective activity [12], and antimicrobial activity [13]. 
Various formulations of green tea are prepared that can be 
beneficial via its antioxidant properties against cellular toxicities 
[14, 15]. This study anticipates in evaluating the anti-hypertrophic 
potential of C. sinensis by ameliorating the effects of isoproterenol 
induced cardiac hypertrophy. 
MATERIALS AND METHODS 
Chemicals  
All the chemicals were purchased as analytical grade from Hi-Media 
Laboratories, India. Isoproterenol was purchased as Isoprenaline 
hydrochloride from Sigma-Aldrich. The standard drug losartan was 
purchased commercially as losarpen (25 mg) tablets from local 
pharmacy, India. The glucose and cholesterol estimation kits were 
purchased from Arkray Healthcare Pvt, Ltd., India. The triglyceride kit 
was purchased from Ensure Biotech Pvt, Ltd., India. The SGOT and 
SGPT kits were purchased from Microlyn Healthcare Pvt, Ltd., India. 
Plant collection and extraction 
The whole plant of Camellia sinensis were collected during the 
month of December, 2017 from the local areas (folklore shops) of 
Coimbatore district, Tamil Nadu, India. The plant was dried in shade 
at room temperature. The dried whole plant was submitted and 
authenticated (No. BSI/SRC/5/23/2017/Tech/1955) at Botanical 
Survey of India, Southern Regional Centre, Coimbatore, India. The 
leaves of C. sinensis were shade dried and powdered in a mixer 
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grinder. The aqueous extract of C. sinensis whole plant was prepared 
with plant powder: water (1:3) cold macerated for 48 h, filtered and 
allowed to dry under controlled temperature to yield the dried leaf 
aqueous extract [16]. 
Procurement of animals 
Young male Albino rats of Wistar strain (200g) procured and the 
Ethical clearance for handling of experimental animals was obtained 
from the Institutional Animal Ethics Committee (IAEC) constituted 
for the purpose and care of laboratory animals as per the guidance 
of the Committee for the Purpose of Control and Supervision of 
Experiments on Animals (CPCSEA), Ministry of Social justice and 
empowerment, Government of India (CPCSEA/No 387/2018/IAEC) 
at the PSG Institute of Medical Sciences and Research (PSG 
IMSandR), Coimbatore. 
Experimental design 
The experimental rats were divided into 4 groups of 6 animals in 
each group. Cardiac hypertrophy was induced to Albino Wistar rats 
using isoproterenol and simultaneous treatment using the plant 
extract and the reference drug, losartan was carried out as shown in 
table 1. 
  
Table 1: Experimental groups of induction and treatment of cardiac hypertrophy 
Groups Experimental animals 
Group I Normal control rats 
Group II Isoproterenol (10 mg/kg b.w., s. c.,7 d)[17] 
Group III Isoproterenol+Losartan (50 mg/kg b.w., oral.,7 d)[18] 
Group IV Isoproterenol+aqueous leaf extract of C. sinensis (100 mg/kg b.w., oral., 7 d)[19] 
 
After the end of the experimental treatment period (7 d), the 
animals were sacrificed under mild chloroform anesthesia. Blood 
was collected by cardiac puncture and the serum was separated 
by centrifugation at 5000 rpm for 10 min. The heart tissue was 
excised immediately and thoroughly washed in saline before use. 
A 10% homogenate of the washed animal tissue was prepared 
using 0.1 M Phosphate buffer (pH 7.4) in potter homogenizer 
fitted with a teflon plunger running at 6000 rpm for 3 min. The 
thus prepared homogenate was used for various biochemical 
assays. 
Biochemical estimation 
Serum glucose was assayed using glucose oxidase method 
(Autospan Liquid Gold Glucose Kit), serum total protein by 
Lowry’s method [20], serum albumin using Bromo cresol green 
end point assay method (Autospan), estimation of serum total 
cholesterol using POD-PAP enzymatic end point assay (Autospan), 
estimations of SGOT and SGPT activities by modified IFCC method 
(Microlyn) and determination of LDH activity by optimized kinetic 
assay method (Autospan) followed by estimation of superoxide 
dismutase (SOD)[21], catalase [22] and glutathione peroxidase 
(GPx) [23]. 
Statistical analysis 
Data obtained was expressed as mean±SD. Statistical analysis was 
performed by using the method of distribution statistics (Standard 
descriptive analysis) and analysis of mean (Student’s‘t’ test) using R-
Statistical Computing and Graphical Tools (formerly AT and T Lucent 
technology). A probability of P<0.05 was considered significant. 
RESULTS AND DISCUSSION 
Effect of ISO and plant extract on the hypertrophic indices 
The gross examination of the heart showed an increase in the heart size 
in the isoproterenol group when compared to the normal group fig. 1. On 
anatomical observation no, remarkable cavity effusions in hypertrophic 
groups were observed. The heart weight/body weight ratio (HW/BW 
ratio) as evident from table 2 was found to be increased by 78.72% in 
the isoproterenol administered rats (group I) when compared to control 
rats (group II), demonstrating an increase in the heart size. However, 
Losartan pretreated rats (group III) showed a 22.78% reduction in the 
HW/BW ratio when compared to isoproterenol administered rats. 
Similar to other studies attenuation of the progression of cardiac 
hypertrophy is indicated with reduced HW/BW ratio in plant extract 
administered groups [24]. 
 
 
Fig. 1: Examination of the heart size in isoproterenol induced experimental rats and C. sinensis treated rats 
 
Table 2: Effect of C. sinensis on the HW/BW ratio in the control and experimental rats 
Groups Heart weight (HW) (mg) Body weight (BW) (g) HW/BW 
Group I 410±10 170±12.92 2.41±0.77 
Group II 475±4.58 187±16.70a* 2.54±0.27a* 
Group III 
a* 
442±2.5 190±17.58b* 2.33±0.14b* 
Group IV 
b* 
456±0.6 190±12.59c* 2.4±0.05c* c* 
Table values are expressed by mean±SD of 6 samples per group. Group comparison: a–Normal (I) Vs ISO (II); b–ISO (II) Vs Drug (III); c–ISO (II) Vs 
Plant extract (IV). Statistical significance (P<0.05) indicated by* 
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Effect of ISO and plant extract on glucose and total protein in 
heart tissue and serum 
Amelioration of cardiac hypertrophy is indicated by significant 
decrease in the elevated levels of glucose, protein, total cholesterol and 
significant increase in reduced HDL cholesterol levels [25]. In 
isoproterenol induced cardiac hypertrophic rats, the glucose, total 
protein and total cholesterol levels in serum and heart tissue were 
significantly (P<0.05) increased considerably with that of the normal 
group. After oral administration of the aqueous leaf extract of C. 
sinensis and losartan the glucose levels were restored in experimental 
animals similar to that of normal control as shown in table 3 and 4. 
 
Table 3: Effect on serum glucose, total protein and total cholesterol 
Groups Serum glucose (mg/g) Serum protein (mg/g) Serum cholesterol (mg/g) 
Group I 109.37±0.26 24±0.56 28.76±0.36 
Group II 141.36±0.27a 38±0a* 65.58±1.007a* 
Group III 
* 
113.41±0.28b 21±1b* 32.09±0.07b* 
Group IV 
* 
119.44±0.325c 16±0.6c* 41.11±0.10c* * 
Table values are expressed by mean±SD of 6 samples per group. Group comparison: a–Normal (I) Vs ISO (II); b–ISO (II) Vs Drug (III); c–ISO (II) Vs 
Plant extract (IV). Statistical significance (P<0.05) indicated by* 
 
Table 4: Effect on glucose, protein and cholesterol in heart tissue 
Groups Tissue glucose (mg/g) Tissue protein (mg/g) Tissue cholesterol (mg/g) Serum HDL (IU/l) 
Group I 108.52±0.26 7±0.56 32.56±0.36 19.50±0.036 
Group II 151.7±0.27a 21±0a* 68.46±1.007a* 65.58±1.007a* 
Group III 
* 
110.14±0.28b 4±1b* 32.92±0.07b* 32.09±0.075b* 
Group IV 
* 
113.44±0.325c 4±0.6c* 36.38±0.10c* 41.11±0.10c* * 
Table values are expressed by mean±SD of 6 samples per group. Group comparison: a–Normal (I) Vs ISO (II); b–ISO (II) Vs Drug (III); c–ISO (II) Vs 
Plant extract (IV). Statistical significance (P<0.05) indicated by* 
 
Effect of ISO and plant extract on cardiac marker enzymes 
Elevated cardiac enzymes are an indication of cardiac hypertrophy 
which is a key risk factor for myocardial infarction [26]. 
Administration of isoproterenol led to a significant (P<0.05) increase 
in levels of SGOT, SGPT and LDH levels in cardiac hypertrophic rats 
when compared with normal control rats. After treatment with 
standard Losartan drug in cardiac hypertrophic rats and plant extract 
to hypertrophic rats for a period of 7 d there was a significant decrease 
in the levels of SGOT, SGPT and LDH as shown in table 5 and 6. 
 
Table 5: Levels of SGOT, SGPT and LDH in serum of control and experimental rats 
Groups Serum SGOT (IU/l) Serum SGPT (IU/l) Serum LDH (IU/l) 
Groups I 0.72±0.009 0.09±0.01 1.08±0.017 
Groups II 0.795±0.03a 0.68±0.06a 1.35±0.005a* 
Groups III 
* 
0.707±0.036b* 0.11±0.004b 1.183±0.12b* 
Groups IV 
* 
0.682±0.057c* 0.08±0.02c 1.064±0.15c* * 
Table values are expressed by mean±SD of 6 samples per group. Group comparison: a–Normal (I) Vs ISO (II); b–ISO (II) Vs Drug (III); c–ISO (II) Vs 
Plant extract (IV). Statistical significance (P<0.05) indicated by* 
 
Table 6: Levels of SGOT, SGPT and LDH in tissue of control and experimental rats 
Groups Tissue SGOT (IU/l) Tissue SGPT (IU/l) Tissue LDH (IU/l) Tissue HDL (IU/l) 
Group I 0.79±0.002 0.19±0.01 1.006±0.002 32.56±1.28 
Group II 0.80±0.005a* 0.34±0.001a 1.07±0.009a* 68.46±1.80a* 
Group III 
* 
0.78±0.001b* 0.07±0.03b 1.35±0.00b* 32.92±1.05b* 
Group IV 
* 
0.697±0.123c* 0.2±0.04c 1.06±0.003c* 36.38±0.28c* * 
Table values are expressed by mean±SD of 6 samples per group. Group comparison: a–Normal (I) Vs ISO (II); b–ISO (II) Vs Drug (III); c–ISO (II) Vs 
Plant extract (IV). Statistical significance (P<0.05) indicated by* 
 
In the present study, treatment with C. sinensis leaf extracts which 
effectively reduced both serum and tissue SGOT, SGPT and LDH 
levels in cardiac hypertrophic rats suggesting that the extracts of 
experimental plant prevent cardiac injury associated with cardiac 
hypertrophy.  
Flavonoids, phenols, carotenoids and glycosides are the major 
phytoconstituent present in the C. sinensis. Catechin is the flavonoid 
compound reported to have cardioprotective activity. 
Effect of ISO and plant extract on enzymic antioxidants 
Regulated antioxidant system is essential for successful therapy to 
treat cardiac hypertrophy [27]. In isoproterenol induced cardiac 
hypertrophic rats, the antioxidant enzymes catalase, SOD, GPx were 
significantly (P<0.05) decreased considerably with that of the 
normal group. Oral administration of the aqueous extract restored 
the above antioxidants in experimental animals similar to that of 
normal control. 
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Table 7: Levels of enzymatic antioxidants in serum of control and experimental rats 
Groups Catalase (IU/l) SOD (IU/l) GPx (IU/l) 
Group I 40.45±0.11 54.74±0.13 29.67±0.1 
Group II 12.11±0.11a 30.9±0.06a* 13.62±1.154a* 
Group III 
* 
23.12±0.06b 43.0±0.19b* 28.60±0.152b* 
Group IV 
* 
20.04±0.04c 46.01±0.1c* 19.34±0.02c* * 
Table values are expressed by mean±SD of 6 samples per group. Group comparison: a–Normal (I) Vs ISO (II); b–ISO (II) Vs Drug (III); c–ISO (II) Vs 
Plant extract (IV). Statistical significance (P<0.05) indicated by* 
 
Table 8: Levels of enzymatic antioxidants in heart of control and experimental rats 
Groups  Catalase (IU/l)  SOD (IU/l)  GPx (IU/l)  
Group I  40.45±0.11 54.74±0.13 29.67±0.1 
Group II  12.11±0.11a 30.9±0.06a* 13.62±1.154a* 
Group III  
* 
23.12±0.06b 43.0±0.19b* 28.60±0.152b* 
Group IV  
* 
20.04±0.04c 46.01±0.1c* 19.34±0.02c* * 
Table values are expressed by mean±SD of 6 samples per group. Group comparison: a–Normal (I) Vs ISO (II); b–ISO (II) Vs Drug (III); c–ISO (II) Vs 
Plant extract (IV). Statistical significance (P<0.05) indicated by* 
 
CONCLUSION 
The present work implies that the aqueous extract of C. sinensis 
leaves restored the serum and heart tissue levels of glucose, protein, 
cholesterol, cardiac markers enzymes (SGOT, SGPT and LDH) and 
enzymatic antioxidants (SOD, Catalase and GPx) which may be due 
to the phytochemical, Catechin present in the plant. Further studies 
may be taken up for the isolation and characterization of catechin 
and also other bioactive antioxidant and cardioprotective 
compounds which may exert potent anti-hypertrophic effects. 
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